FIELD: medicine.
SUBSTANCE: invention can be used for screening of anti-tumour preparations in vivo, in particular for screening synthetic and natural substances with potential anti-tumour activity.
EFFECT: claimed invention makes it possible to create stable cell line of human ovarian adenocarcinoma.
2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE HUMAN BREAST CANCER CARCINOMA CELL LINE SKBR-KAT | 2018 |
|
RU2709675C1 |
| RECOMBINANT IMMUNOTOXIN, SPECIFIC TO THE CELLS EXPRESSING HER2 RECEPTOR | 2014 |
|
RU2576232C1 |
| METHOD OF STIMULATING ANTI-TUMOUR ACTIVITY OF CYTOTOXIC EFFECTORS OF IMMUNE SYSTEM | 2010 |
|
RU2429005C1 |
| PHARMACEUTICAL COMPOSITION BASED ON TRIINDOLYLMETHANE DERIVATIVE AS ANTI-TUMOUR MEDICATION | 2012 |
|
RU2549430C2 |
| METHOD OF PRODUCING RECOMBINANT ANTI-TUMOR TOXIN BASED ON PROTEIN BARNASE-BARSTAR AND TARGETED POLYPEPTIDE DARPIN WITH EFFECT OF INSTANT CANCELLATION OF CYTOTOXIC ACTION | 2015 |
|
RU2610179C1 |
| TEST SYSTEM FOR DETERMINING THE LEVEL OF CHROMOSOMAL INSTABILITY, A METHOD FOR SCREENING ANTITUMOR DRUG CANDIDATES THAT CAUSE CHROMOSOMAL INSTABILITY, AND A METHOD FOR SEARCHING FOR GENES THAT CONTROL CHROMOSOME TRANSMISSION | 2020 |
|
RU2744383C1 |
| METHOD FOR ESTIMATION OF TOTAL INDICATOR OF ANEUPLOIDY AND PROLIFERATIVE ACTIVITY OF TUMOUR CELLS OF NON-SMALL-CELL LUNG CANCER AND OVARIAN CANCER USING SPECIFIC DNA DYE DRAQ7 OF NEW GENERATION | 2016 |
|
RU2639251C1 |
| COMPLEX FOR THE DETECTION AND TARGETED DESTRUCTION OF CELLS | 2019 |
|
RU2743993C1 |
| FLUORESCENT CELL LINE mel Kor-TurboRFP AND METHOD FOR USING IT FOR IN VITRO STUDIES IN EXPERIMENTAL ONCOLOGY | 2009 |
|
RU2458123C2 |
| METHOD OF OBTAINING A RADIOCHEMICAL COMPOUND BASED ON IODINE-123 LABELED RECOMBINANT ADDRESSED PROTEIN MOLECULES WITH ANKYRIN REPEATS FOR VISUALIZING CANCER WITH HER2/neu OVEREXPRESSION | 2023 |
|
RU2815777C1 |
